RGT — Argent BioPharma Share News
0.000.00%
Last trade - 00:00- AU$3.17m
- AU$3.02m
- AU$0.18m
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group
Brief: Argent Biopharma And Auscann Enters Strategic Heads Of Agreement
Brief: Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta
Brief: Argent Biopharma Says Cannepil Receives Approval For Prescription In Germany
Brief: Argent BioPharma Reports Agreement For Malta Manufacturing Facility
Brief: Argent Biopharma Announces Strategic Partnership With ECCPharm
Australia's Argent BioPharma rises on partnership with ECCPharm
Brief: Argent BioPharma Posts HY Net Loss Attributable A$12.2 Million
Australia's Argent BioPharma rises most in over 3 months on premium capital raising
Brief: Argent Biopharma Seeks Trading Halt
Additional Information for Shareholders
Brief: Argent Biopharma Ltd To Delist from London Stock Exchange
Brief: Argent Biopharma Announces Intention To Delist From London Stock Exchange
September 2024 Quarterly Report
Dispatch of Annual General Meeting Documents
Placing to Raise A$200,000